Column-switching high-performance liquid chromatographic analysis of fluvastatin in rat plasma by direct injection

Journal of Pharmaceutical and Biomedical Analysis

Volumn 41, Issue 4, 2006, Pages 1458-1462

  Um, So Young ^a   Jung, Sung Hee ^a   Jung, Seo Jeong ^a   Kim, Joo Il ^a   Chung, Soo Youn ^a   Lee, Hwa Jeong ^b   Han, Sang Beom ^c   Choi, Sun Ok ^a  

^a National Institute of Toxicological Research   (South Korea)

^b Ewha Womans University   (South Korea)

^c Chung Ang University   (South Korea)

Author keywords

Column switching; Direct injection; Fluvastatin; High performance liquid chromatography (HPLC); Rat plasma

Indexed keywords

ACETONITRILE; FLUINDOSTATIN; POTASSIUM DIHYDROGEN PHOSPHATE;

ANIMAL EXPERIMENT; ARTICLE; COLUMN CHROMATOGRAPHY; DRUG BLOOD LEVEL; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PLASMA; PRIORITY JOURNAL; RAT;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; FATTY ACIDS, MONOUNSATURATED; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INDOLES; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS;

EID: 33646915183     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2006.03.021     Document Type: Article

References (20)

1. Al-Rawithi S., Hussein R.F., and Alzahrani A. Ther. Drug Monit. 25 (2003) 88
2. Kathawala F.G. Med. Res. Rev. 11 (1991) 121
3. Davignon J., Montigny M., and Dufcur R. Can. J. Cardiol. 8 (1992) 843
4. Kalafsky G., and Smith H.T. J. Chromatogr. 614 (1993) 307
5. Erturk S., Onal A., and Cetin S.M. J. Chromatogr. B 793 (2003) 193
6. Fairhurst R.E., Chassaing C., Venn R.F., and Mayes A.G. Biosens. Bioelectron. 15 (2004) 1098
7. Ayrton J., Dear G.J., Leavens W.J., Mallett D.N., and Plumb R.S. Rapid Commun. Mass. Spectom. 11 (1997) 1953
8. Jarmalaviciene R., Kornysova O., Westerlund D., and Maruska A. Anal. Bioanal. Chem. 377 (2003) 902
9. Rbeida O., Christiaens B., Hubert Ph., Lubda D., Boos K.-S., Crommen J., and Chiap P. J. Chromatogr. A 1030 (2004) 95
10. De Nardi C., Ferrari L., Nardin E., Ruffo A., and Braggio S. J. Chromatogr. B 752 (2001) 134
11. Takano T., Kagami Y., Kuwabara Y., and Hata S. J. Chromatogr. B: Biomed. Appl. 656 (1994) 353
12. Wong B.K., Bruhin P.J., and Lin J.H. J. Chromatogr. B: Biomed. Appl. 655 (1994) 158
13. Musson D.G., Birk K.L., Cairns A.M., Majumdar A.K., and Rogers J.D. J. Chromatogr. B 720 (1998) 99
14. Choi S.J., Kim S.B., Lee H.Y., Na D.H., Yoon Y.S., Lee S.S., Kim J.H., Lee K.C., and Lee H.S. Talanta 54 (2001) 380
15. Food and Drug Administration, Center for Drug Evaluation and Research, Guidance for Industry, Bioanalytical Method Validation, 2001.
16. Toreson H., and Eriksson B.M. J. Chromatogr. A 729 (1996) 13
17. Lanchote V.L., Rocha A., de Albuquerque F.U., Coelho E.B., and Bonato P.S. J. Chromatogr. B 765 (2001) 81
18. Kang S.H., Chang S.Y., Do K.C., Chi S.C., and Chung D.S. J. Chromatogr. B 712 (1998) 154
19. Lee H.S., Kim K., Kim J.H., Do K.S., and Lee S.K. J. Chromatogr. B 716 (1998) 373
20. Shah V.P., Midha K.K., Dighe S., McGliveray I.J., Skelly J.P., Jacobi T.A., Layoff T., Viswanathan C.T., Cook C.E., McDowall R.D., Pittman K.A., and Spector S. J. Pharm. Sci. 81 (1992) 309